• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Merck & Co (NY: MRK )

    126.06 +1.81 (+1.46%)
    Streaming Delayed Price Updated: 1:57 PM EDT, Jul 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,526,708
    Open 125.30
    Bid (Size) 126.04 (3)
    Ask (Size) 126.06 (2)
    Prev. Close 124.25
    Today's Range 125.18 - 126.99
    52wk Range 99.14 - 134.63
    Shares Outstanding 2,531,374,696
    Dividend Yield 2.32%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
    The Nasdaq tumbled amid chip woes. 
    Via Investor's Business Daily
    Merck & Co Inc. DCF Valuation: Is The Stock Undervalued?
    Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. 
    Via Talk Markets

    Performance

    YTD
    +11.32%
    +11.32%
    1 Month
    -1.51%
    -1.51%
    3 Month
    +0.66%
    +0.66%
    6 Month
    +6.34%
    +6.34%
    1 Year
    +18.98%
    +18.98%

    More News

    Read More
    Merck Gets Legal Victory As Appeals Court Dismisses Shingles Vaccine Some 1,200 Lawsuits
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Legal
    Merck & Co's Options Frenzy: What You Need to Know
    Via Benzinga
    2 Magnificent Stocks to Buy With $500
    Via The Motley Fool
    Evaluating Merck & Co Against Peers In Pharmaceuticals Industry
    Via Benzinga
    NYSE:MRK is probably undervalued for the fundamentals it is displaying.
    Via Chartmill
    Merck's Acquisition of EyeBio Finalized
    Via Benzinga
    3 Top Cancer Treatment Stocks to Buy Now
    Via InvestorPlace
    3 Biotech Stocks to Buy in Case of Another Pandemic
    Via InvestorPlace
    Merck to Share New Research and Host Community-Focused Symposia at AIDS 2024
    From Merck & Co., Inc.
    Via Business Wire
    Forget Nvidia: Billionaires Are Dumping It and Piling Into These 3 Surprising Value Stocks Instead
    Via The Motley Fool
    Beyond The Numbers: 6 Analysts Discuss Merck & Co Stock
    Via Benzinga
    Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
    Via Benzinga
    Topics Bankruptcy
    Exposures Financial Legal
    Positive News is Driving This Cancer Drug Maker’s Stock Higher
    Via MarketBeat
    Australia Based Cancer Focused Immutep's Lead Cancer Drug Shows 'Meaningful Response' In Untreated Head & Neck Cancer, Stock Soars
    Via Benzinga
    Merck Completes Acquisition of EyeBio
    From Merck & Co., Inc.
    Via Business Wire
    3 Under-$10 Biotech Stocks That Could Make You Rich
    Via InvestorPlace
    7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns
    Via InvestorPlace
    S&P 500 2024 Q2 Earnings Preview: Aggregate Earnings Reaching A New High Watermark?
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem
    Via MarketBeat
    Merk Animal Health Completes Acquisition of Elanco Animal Health Assets
    Via Benzinga
    3 Undervalued Blue-Chip Stocks Ready for a Big Comeback
    Via InvestorPlace
    Merck Animal Health Completes Acquisition of Elanco’s Aqua Business
    From Merck & Co., Inc.
    Via Business Wire
    Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
    Via Talk Markets
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.